Global Life Sciences Trends And Opportunities 2012-2015
NEW YORK, April 2, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Life Sciences Trends and Opportunities 2012-2015 http://www.reportlinker.com/p01075843/Global-Life-Sciences-Trends-and-Opportunities-2012-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Frost & Sullivan's global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivan's proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.
TABLE OF CONTENTSExecutive Summary 6Daunting Challenges for the Pharmaceutical Industry 12Pharma's New Growth Strategies 17Curbing the Costs of Drug Development 32Lean Laboratories—Doing More With Less 37Novel Biomarker Discovery Leading to Novel Therapeutics 41Genetic Technologies are Integral to Healthcare 47Conclusions 52Appendix 55The Frost & Sullivan Story 65 List of ExhibitsLife Sciences Trends and Opportunities: Executive Summary, Global, 2012-2015 7Life Sciences Trends and Opportunities: Growth Areas Now and Developing, Global, 2012-2015 8Life Sciences Trends and Opportunities: Companies to Watch, Global, 2012-2015 9Life Sciences Trends and Opportunities: Competitive Companies Tracked by Frost & Sullivan, Global, 2012 10Life Sciences Trends and Opportunities: Future Outlook for Healthcare Compared to Present, Global, 2012-2015 11Life Sciences Trends and Opportunities: Key Mergers and Acquisitions by Pharmaceutical Companies, Global, 2010-2012 14Life Sciences Trends and Opportunities: Open Innovation—Pfizer and Novartis, Global, 2011 24Life Sciences Trends and Opportunities: Open Innovation—GlaxoSmithKline and Eli Lilly, Global, 2011 25Life Sciences Trends and Opportunities: Healthcare Expenditure, Global, 2010-2020 26Life Sciences Trends and Opportunities: Co-development Models, U.S., 2012 36Non-Invasive Prenatal Testing Market: Level of Agreement that NIPT Should Replace Maternal Serum Screen, U.S., 2012 51Life Sciences Trends and Opportunities: Patent Expirations for Major Drugs, U.S., 2011-2016 56Life Sciences Trends and Opportunities: Patent Expirations for Top Biologics, U.S., 2011-2019 57Life Sciences Trends and Opportunities: Top M&A Deals, U.S., 2011-2016 59 To order this report: Global Life Sciences Trends and Opportunities 2012-2015 __________________________Contact Clare: firstname.lastname@example.org US:(339) 368 6001 Intl:+1 339 368 6001 SOURCE Reportlinker
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts